Randomized phase 2 trial of erlotinib in combination with high-dose celecoxib or placebo in patients with advanced non-small cell lung cancer
Reckamp, Karen L., Koczywas, Marianna, Cristea, Mihaela C., Dowell, Jonathan E., Wang, He-Jing, Gardner, Brian K., Milne, Ginger L., Figlin, Robert A., Fishbein, Michael C., Elashoff, Robert M., DubinVolume:
121
Langue:
english
Journal:
Cancer
DOI:
10.1002/cncr.29480
Date:
September, 2015
Fichier:
PDF, 399 KB
english, 2015